Mosaic ImmunoEngineering (CPMV) Change in Accured Expenses (2010 - 2026)

Mosaic ImmunoEngineering's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $116161.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 2355.55% year-over-year to $116161.0; the TTM figure through Mar 2026 stood at $129621.0 (down 68.81% YoY), while the FY2025 annual figure was $8310.0, down 98.57% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $116161.0, up from -$2887.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $590880.0 in Q3 2023, with the low at -$537706.0 in Q4 2023.
• The 5-year median for Change in Accured Expenses is $10784.0 (2022), against an average of $64647.2.
• The sharpest annual moves came in 2023 and 2026: Change in Accured Expenses plunged 6149.8% in 2023, then surged 2355.55% in 2026.
• Mosaic ImmunoEngineering's Change in Accured Expenses stood at $8888.0 in 2022, then slumped by 6149.8% to -$537706.0 in 2023, then soared by 123.4% to $125802.0 in 2024, then plunged by 102.29% to -$2887.0 in 2025, then soared by 4123.59% to $116161.0 in 2026.
• Business Quant data shows CPMV's Change in Accured Expenses at $116161.0 in Q1 2026, -$2887.0 in Q4 2025, and $21415.0 in Q3 2025.